Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Peters Medical Research
mi
from
HIgh Point, NC
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Peters Medical Research
mi
from
HIgh Point, NC
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Elite Clinical Studies
mi
from
Phoenix, AZ
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Elite Clinical Studies
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Lillestol Research LLC
mi
from
Fargo, ND
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Lillestol Research LLC
mi
from
Fargo, ND
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinvest Research
mi
from
Springfield, MO
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinvest Research
mi
from
Springfield, MO
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials of Neurology
mi
from
Austin, TX
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Neurology
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Achieve Clinical Research
mi
from
Birmingham, AL
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Downtown L.A. Research Center, Inc.
mi
from
Los Angeles, CA
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Downtown L.A. Research Center, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
California Medical Clinic for Headache
mi
from
Santa Monica, CA
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
California Medical Clinic for Headache
mi
from
Santa Monica, CA
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Colorado Allergy and Asthma Centers, PC
mi
from
Denver, CO
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Colorado Allergy and Asthma Centers, PC
mi
from
Denver, CO
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Advanced Clinical Research, Inc.
mi
from
Meridian, ID
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Advanced Clinical Research, Inc.
mi
from
Meridian, ID
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Research Institute Inc.
mi
from
Minneapolis, MN
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Institute Inc.
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Research Institute Inc
mi
from
Plymouth, MN
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Institute Inc
mi
from
Plymouth, MN
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Central Texas Health Research
mi
from
New Braunfels, TX
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Central Texas Health Research
mi
from
New Braunfels, TX
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Empire Clinical Research
mi
from
Upland, CA
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Empire Clinical Research
mi
from
Upland, CA
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Harmony Medical Research Institute, Inc
mi
from
Hialeah, FL
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Harmony Medical Research Institute, Inc
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
MedVadis Research Corporation
mi
from
Watertown, MA
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
MedVadis Research Corporation
mi
from
Watertown, MA
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Michigan Headache & Neurological Institute
mi
from
Ann Arbor, MI
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Michigan Headache & Neurological Institute
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Allergy & Asthma Associates of Santa Clara Valley Research Center
mi
from
San Jose, CA
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Allergy & Asthma Associates of Santa Clara Valley Research Center
mi
from
San Jose, CA
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
DelRicht Research
mi
from
New Orleans, LA
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
DelRicht Research
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Boston Clinical Trials, INC.
mi
from
Boston, MA
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Boston Clinical Trials, INC.
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
North Carolina Clinical Research
mi
from
Raleigh, NC
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
North Carolina Clinical Research
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Raleigh Medical Group PMG Research
mi
from
Raleigh, NC
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Raleigh Medical Group PMG Research
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Primary Care Associates/Radiant Research
mi
from
Anderson, SC
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Primary Care Associates/Radiant Research
mi
from
Anderson, SC
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Stanford University Medical Center
mi
from
Palo Alto, CA
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Stanford University Medical Center
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center - Neurology Clinic
mi
from
Dallas, TX
A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
A Long-Term, Open-Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center - Neurology Clinic
mi
from
Dallas, TX
Click here to add this to my saved trials
The Utility of Telemedicine in the Management of Migraine
The Utility of Telemedicine in the Management of Migraine: A Pilot Study :MK0974-071-00
Status: Enrolling
Updated:  12/31/1969
Universit of Texas Southwestern
mi
from
Dallas, TX
The Utility of Telemedicine in the Management of Migraine
The Utility of Telemedicine in the Management of Migraine: A Pilot Study :MK0974-071-00
Status: Enrolling
Updated: 12/31/1969
Universit of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study of SOM230 s.c. in Cluster Headache
A Multicenter, Placebo-Controlled, Single Dose Study in Acute Episodic and Chronic Cluster Headache to Evaluate the Safety and Efficacy of SOM230 Subcutaneous (s.c.)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Culver City, CA
Safety and Efficacy Study of SOM230 s.c. in Cluster Headache
A Multicenter, Placebo-Controlled, Single Dose Study in Acute Episodic and Chronic Cluster Headache to Evaluate the Safety and Efficacy of SOM230 Subcutaneous (s.c.)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Culver City, CA
Click here to add this to my saved trials
Safety and Efficacy Study of SOM230 s.c. in Cluster Headache
A Multicenter, Placebo-Controlled, Single Dose Study in Acute Episodic and Chronic Cluster Headache to Evaluate the Safety and Efficacy of SOM230 Subcutaneous (s.c.)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Philadelphia, PA
Safety and Efficacy Study of SOM230 s.c. in Cluster Headache
A Multicenter, Placebo-Controlled, Single Dose Study in Acute Episodic and Chronic Cluster Headache to Evaluate the Safety and Efficacy of SOM230 Subcutaneous (s.c.)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy Study of SOM230 s.c. in Cluster Headache
A Multicenter, Placebo-Controlled, Single Dose Study in Acute Episodic and Chronic Cluster Headache to Evaluate the Safety and Efficacy of SOM230 Subcutaneous (s.c.)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Königstein im Taunus,
Safety and Efficacy Study of SOM230 s.c. in Cluster Headache
A Multicenter, Placebo-Controlled, Single Dose Study in Acute Episodic and Chronic Cluster Headache to Evaluate the Safety and Efficacy of SOM230 Subcutaneous (s.c.)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Königstein im Taunus,
Click here to add this to my saved trials
Olanzapine for Acute Headaches
Oral Rapidly Dissolving Olanzapine for Acute Primary Headache in the Emergency Department Setting: A Feasibility Trial
Status: Enrolling
Updated:  12/31/1969
Regions Hospital
mi
from
Saint Paul, MN
Olanzapine for Acute Headaches
Oral Rapidly Dissolving Olanzapine for Acute Primary Headache in the Emergency Department Setting: A Feasibility Trial
Status: Enrolling
Updated: 12/31/1969
Regions Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Corticosteroids for Acute Migraine in the Emergency Department
Corticosteroids for Acute Migraine. An ED-based, Randomized, Comparative Effectiveness Trial
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center (Einstein)
mi
from
Bronx, NY
Corticosteroids for Acute Migraine in the Emergency Department
Corticosteroids for Acute Migraine. An ED-based, Randomized, Comparative Effectiveness Trial
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center (Einstein)
mi
from
Bronx, NY
Click here to add this to my saved trials
Corticosteroids for Acute Migraine in the Emergency Department
Corticosteroids for Acute Migraine. An ED-based, Randomized, Comparative Effectiveness Trial
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center--Moses
mi
from
Bronx, NY
Corticosteroids for Acute Migraine in the Emergency Department
Corticosteroids for Acute Migraine. An ED-based, Randomized, Comparative Effectiveness Trial
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center--Moses
mi
from
Bronx, NY
Click here to add this to my saved trials
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Northwell Health, Inc
mi
from
New York, NY
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Northwell Health, Inc
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Rambam Medical Center
mi
from
Haifa,
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Rambam Medical Center
mi
from
Haifa,
Click here to add this to my saved trials
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Hartford Headache Center
mi
from
Hartford, CT
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Hartford Headache Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital
mi
from
Saint Louis, MO
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinvest Research
mi
from
Springfield, MO
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinvest Research
mi
from
Springfield, MO
Click here to add this to my saved trials
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Reseach Consortium
mi
from
Las Vegas, NV
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Reseach Consortium
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Evaluation of a Novel Device for Treatment of Migraine Headache
A Randomized, Double Blinded, Sham Controlled Clinical Study to Evaluate the Safety and Efficacy of the Nerivio Migra 1, a Neuromodulation Device, for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effects of Cervical Manual Therapy on Cervicogenic Headache
Effects of Cervical Spine Manual Therapy on Range of Motion, Joint Position Sense, and Balance in Participants With Cervicogenic Headache
Status: Enrolling
Updated:  12/31/1969
Shenandoah University
mi
from
Winchester, VA
Effects of Cervical Manual Therapy on Cervicogenic Headache
Effects of Cervical Spine Manual Therapy on Range of Motion, Joint Position Sense, and Balance in Participants With Cervicogenic Headache
Status: Enrolling
Updated: 12/31/1969
Shenandoah University
mi
from
Winchester, VA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Dosing Regimens Of Oral AGN-241689 In Episodic Migraine Prevention
Status: Enrolling
Updated:  12/31/1969
Achieve Clinical Research
mi
from
Birmingham, AL
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Dosing Regimens Of Oral AGN-241689 In Episodic Migraine Prevention
Status: Enrolling
Updated: 12/31/1969
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Dosing Regimens Of Oral AGN-241689 In Episodic Migraine Prevention
Status: Enrolling
Updated:  12/31/1969
Radiant Research
mi
from
Chandler, AZ
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Dosing Regimens Of Oral AGN-241689 In Episodic Migraine Prevention
Status: Enrolling
Updated: 12/31/1969
Radiant Research
mi
from
Chandler, AZ
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Dosing Regimens Of Oral AGN-241689 In Episodic Migraine Prevention
Status: Enrolling
Updated:  12/31/1969
The Research Center of Southern California
mi
from
Carlsbad, CA
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Dosing Regimens Of Oral AGN-241689 In Episodic Migraine Prevention
Status: Enrolling
Updated: 12/31/1969
The Research Center of Southern California
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Dosing Regimens Of Oral AGN-241689 In Episodic Migraine Prevention
Status: Enrolling
Updated:  12/31/1969
Neuro-Pain Medical Center
mi
from
Fresno, CA
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Dosing Regimens Of Oral AGN-241689 In Episodic Migraine Prevention
Status: Enrolling
Updated: 12/31/1969
Neuro-Pain Medical Center
mi
from
Fresno, CA
Click here to add this to my saved trials